• ISSN: 2349-6002
  • UGC Approved Journal No 47859

DEVELOPMENT AND CHARACTERIZATION OF QUINAPRIL CO-CRYSTALS USING NEUTRACEUTICALS AS CO-FORMERS

  • Unique Paper ID: 158977
  • Volume: 9
  • Issue: 11
  • PageNo: 97-101
  • Abstract:
  • The co-crystals of quinapril were developed by solvent evaporation method and using nutraceuticals as co-formers such as quercetin, nicotinic acid, curcumin, and caffeine in 1:2 equimolar ratio and observed effect on drug release pattern. The developed co-crystals were tested in pre and post-compression parameters. All formulation findings have been determined to be within pharmacopeial limits. The most significant percentage of drug release for 2 hrs was 99.84% in the optimized formulation (F1) compared with the marketed product (Accupril). The SEM studies showed that optimized formulation (F1) good uniformity as well as crystalline nature. The Higuchi model offers an R2 value of 0.983, indicating that the drug release was followed by non-fickian diffusion.
email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 11
  • PageNo: 97-101

DEVELOPMENT AND CHARACTERIZATION OF QUINAPRIL CO-CRYSTALS USING NEUTRACEUTICALS AS CO-FORMERS

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry